Francois-Xavier Lepelletier
Overview
Explore the profile of Francois-Xavier Lepelletier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lepelletier F, Vandesquille M, Asselin M, Prenant C, Robinson A, Mann D, et al.
Theranostics
. 2022 Aug;
12(12):5335-5336.
PMID: 35910804
[This corrects the article DOI: 10.7150/thno.47585.].
2.
Lepelletier F, Vandesquille M, Asselin M, Prenant C, Robinson A, Mann D, et al.
Theranostics
. 2020 Jul;
10(18):7938-7955.
PMID: 32724451
The sigma 1 receptor (S1R) is widely expressed in the CNS and is mainly located on the endoplasmic reticulum. The S1R is involved in the regulation of many neurotransmission systems...
3.
Nicolas C, Tauber C, Lepelletier F, Chalon S, Belujon P, Galineau L, et al.
Neuropsychopharmacology
. 2017 May;
42(10):1981-1990.
PMID: 28553833
The chronic and relapsing nature of addiction suggests that drugs produce persistent adaptations in the brain that make individuals with drug addiction particularly sensitive to drug-related cues and stress and...
4.
Sridharan S, Lepelletier F, Trigg W, Banister S, Reekie T, Kassiou M, et al.
Mol Imaging Biol
. 2016 Aug;
19(1):77-89.
PMID: 27481358
Purpose: Over the past 20 years, neuroinflammation (NI) has increasingly been recognised as having an important role in many neurodegenerative diseases, including Alzheimer's disease. As such, being able to image...
5.
Lepelletier F, Tauber C, Nicolas C, Solinas M, Castelnau P, Belzung C, et al.
Int J Neuropsychopharmacol
. 2014 Dec;
18(4).
PMID: 25522388
Background: Methylphenidate (MPH) is a commonly-used medication for the treatment of children with Attention-Deficit/Hyperactivity Disorders (ADHD). However, its prescription to adults with ADHD and narcolepsy raises the question of how...
6.
Leconte C, Bihel E, Lepelletier F, Bouet V, Saulnier R, Petit E, et al.
Neuropharmacology
. 2010 Oct;
60(2-3):354-64.
PMID: 20932982
Erythropoietin (EPO), a well known haematopoietic growth factor, possesses neuroprotective and neurotrophic effects which have been recently reported to improve cognition and to modulate emotional processing. We investigated the effects...